CIK 0001710340 · Non-accelerated filer<br>Smaller reporting company
Eton Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ETON
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 371858472
- Phone
- (847) 787-7361
- Business address
- 21925 W. FIELD PARKWAY, SUITE 235, DEER PARK, IL, 60010-7278
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $19,432,082
- in 7 filings
Net −$19,432,082. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-31 | Matthews Judith M. Chief Financial Officer | Grant or award · Common Stock | +32,246 | 32,246 | ||
| 2026-07-31 | Erdogan-Trinkaus Ipek Chief Commercial Officer | Grant or award · Common Stock | +80,000 | 80,000 | ||
| 2026-07-31 | BRYNJELSEN SEAN President & CEO | Grant or award · Common Stock | +128,985 | 128,985 | ||
| 2026-07-31 | Krempa David Chief Business Officer | Grant or award · Common Stock | +128,985 | 128,985 | ||
| 2026-07-31 | MAIER PAUL V Director | Grant or award · Common Stock | +10,000 | 10,000 | ||
| 2026-07-31 | RIEDEL NORBERT G Director | Grant or award · Common Stock | +10,000 | 10,000 | ||
| 2026-07-31 | Adams Jennifer McKie Director | Grant or award · Common Stock | +10,000 | 10,000 | ||
| 2026-07-14 | Opaleye Management Inc. 10% owner | Sale | −15,000 | $37.54 | $563K | 2,665,000 |
| 2026-07-14 | Opaleye Management Inc. 10% owner | Sale | −13,315 | $37.54 | $500K | 40,000 |
| 2026-07-14 | Opaleye Management Inc. 10% owner | Sale | −15,000 | $37.54 | $563K | 2,665,000 |
| 2026-07-14 | Opaleye Management Inc. 10% owner | Sale | −13,315 | $37.54 | $500K | 40,000 |
| 2026-07-14 | BRYNJELSEN SEAN President & CEO | Option exercise | +200,000 | $1.37 | $274K | 1,061,194 |
| 2026-07-14 | BRYNJELSEN SEAN President & CEO | Option exercise · Employee Stock Option | +200,000 | 0 | ||
| 2026-07-12 | BRYNJELSEN SEAN President & CEO | Option exercise | +27,500 | 861,194 | ||
| 2026-07-12 | BRYNJELSEN SEAN President & CEO | Option exercise · Restricted Stock Units | −27,500 | 0 | ||
| 2026-07-12 | Krempa David Chief Business Officer | Option exercise | +10,000 | 37,025 | ||
| 2026-07-12 | Krempa David Chief Business Officer | Option exercise · Restricted Stock Units | −10,000 | 0 | ||
| 2026-07-07 | Opaleye Management Inc. 10% owner | Sale | −20,000 | $38.37 | $767K | 2,680,000 |
| 2026-07-07 | Opaleye Management Inc. 10% owner | Sale | −6,685 | $38.37 | $257K | 53,315 |
| 2026-07-06 | Opaleye Management Inc. 10% owner | Sale | −10,000 | $38.00 | $380K | 2,700,000 |
Page 3 of 13 · 249 trades